Salugan, Nina H.

HRN: 26-48-68  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/19/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/19/2026
06/25/2026
IV
1.5g
Q6h
Bed Sore
Remove - Pending Acceptance
06/19/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/19/2026
06/25/2026
IV
600mg
Q8h
Bed Sore
Remove - Pending Acceptance
06/20/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/20/2026
06/20/2026
IV
4.5
Loading Dose
Sacral Ulcer
Remove - Pending Acceptance
06/20/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
06/20/2026
06/26/2026
IV
2.25
8q
Sacral Ulcer
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: